Shopping Cart

AngioDynamics Inc (ANGO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SKU
GDPH215D
READ MORE
USD 250
Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

AngioDynamics Inc (AngioDynamics) is a provider of medical, surgical and diagnostic devices. Its major products include peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products

READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

AngioDynamics Inc (AngioDynamics) is a provider of medical, surgical and diagnostic devices. Its major products include peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. The company's products are used by interventional radiologists, interventional cardiologists, surgeons and physicians for the minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. The company sells its products through direct sales force in the US and through a network of distributors outside the US. The company has operations in North America, Europe and Asia. AngioDynamics is headquartered in New York, the US.

AngioDynamics Inc (ANGO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AngioDynamics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

AngioDynamics Inc, Medical Devices Deals, 2011 to YTD 2017 9

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

AngioDynamics Enters into Distribution Agreement with Merz North America for Asclera 11

Licensing Agreements 11

Acacia Enters Into Licensing Agreement With AngioDynamics 11

Equity Offering 12

AngioDynamics Prices Public Offering of Shares for USD38 Million 12

AngioDynamics Prices Public Offering of Shares for USD32 Million 13

AngioDynamics Inc-Key Competitors 15

Key Employees 16

Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 19

Financial Announcements 19

Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 19

Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 21

Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 23

Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 24

Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results 26

Corporate Communications 28

Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 28

Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 29

Apr 04, 2016: AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

AngioDynamics Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

AngioDynamics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AngioDynamics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AngioDynamics Inc, Deals By Therapy Area, 2011 to YTD 2017 8

AngioDynamics Inc, Medical Devices Deals, 2011 to YTD 2017 9

AngioDynamics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

AngioDynamics Enters into Distribution Agreement with Merz North America for Asclera 11

Acacia Enters Into Licensing Agreement With AngioDynamics 11

AngioDynamics Prices Public Offering of Shares for USD38 Million 12

AngioDynamics Prices Public Offering of Shares for USD32 Million 13

AngioDynamics Inc, Key Competitors 15

AngioDynamics Inc, Key Employees 16

AngioDynamics Inc, Other Locations 17

AngioDynamics Inc, Subsidiaries 17

To know more information on Purchase by Section, please send a mail to

Products

AngioDynamics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.